Tyagarajan Seshu, Chief Technology Officer at Candel Therapeutics ($CADL), made two open market sales of company shares over the past year, totaling $552 thousand. His latest sale occurred on March 17, 2025. These transactions rank 6,224th among 11,678 insiders by sale value, well below the average of 8.6 million across 6.4 sales per insider. Seshu recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | A | Stock Option (Right to Buy) | 154000 | $0.00 | 154,000.0000 | 55,018,457 | 9999.99% | 0.28% |
| June 25, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | A | Common Stock | 5353 | $4.67 | 90,865.0000 | 46,933,088 | 6.26% | 0.01% |
| March 17, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 70,000.0000 | 46,933,088 | 22.22% | 0.04% |
| March 17, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 31278 | $8.82 | 85,512.0000 | 46,933,088 | 26.78% | 0.07% |
| March 17, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | M | Common Stock | 20000 | $1.29 | 116,790.0000 | 46,933,088 | 20.66% | 0.04% |
| March 17, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 70,000.0000 | 46,933,088 | 22.22% | 0.04% |
| March 17, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 31278 | $8.82 | 85,512.0000 | 46,933,088 | 26.78% | 0.07% |
| Feb. 12, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 46,933,088 | 9999.99% | 0.14% |
| Jan. 15, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 14322 | $7.23 | 96,790.0000 | 46,933,088 | 12.89% | 0.03% |
| Jan. 8, 2025 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 14545 | $8.22 | 111,112.0000 | 46,933,088 | 11.58% | 0.03% |
| Nov. 29, 2024 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 20392 | $4.56 | 125,657.0000 | 32,247,744 | 13.96% | 0.06% |
| July 17, 2024 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 14851 | $6.47 | 146,049.0000 | 31,186,817 | 9.23% | 0.05% |
| July 11, 2024 | Candel Therapeutics, Inc. | $CADL | Tyagarajan Seshu | Chief Technology Officer | S | Common Stock | 13330 | $5.97 | 160,900.0000 | 31,186,817 | 7.65% | 0.04% |